In reaction to disappointing earnings/guidance: n/a
Other news:
Other news:
- ELGX -16.6% (Endologix announces temporary hold on shipments of its AFX Endovascular AAA System to complete investigation of manufacturing issue with some sizes)
- BAS -10% (successfully completes prepackaged restructuring and emerges from Chapter 11 with $125 million of new capital and debt level reduced by $775 million)
- AVXS -5.2% (following IONS/BIIB spinal muscular atrophy drug approval news)
- HMNY -4.5% (filed for 3,926,293 share common stock offering by selling security holders)
- AMRS -4.5% (filed for offering of 10 mln shares of common stock on behalf of selling stockholders)
- RBA -3.1% (light volume; reported auction update and was downgraded at Raymond James)
- AMPH -2.3% (receives complete response letter for Primatene mist from the FDA)
- DB -2.2% (following weakness in overseas trade)
Analyst comments:
- GPRO -0.3% (cautious Piper commentary regarding holiday sales)